You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.
According to BBC News, the UK is to launch its new "high-risk" science agency.
The UK has given the go-ahead to a SARS-CoV-2 human challenge trial, Reuters reports.
University of Oxford researchers are investigating whether combining different COVID-19 vaccines provides the same or better protection than one type of vaccine alone, Business Insider says.
The UK expands community testing in response to new "mutations of concern," the Guardian writes.
The new UK business secretary is moving ahead with establishing a research agency modeled on the US Advanced Research Projects Agency, according to the Financial Times.
The Wall Street Journal reports on the UK's SARS-CoV-2 genomic surveillance approach.
The service will offer whole-genome sequencing to English patients with rare diseases and cancer as part of routine care.
The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.
A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.
The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.
The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.
In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.